Renaissance Technologies (RenTech)'s DNA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 100,456 shares of Ginkgo Bioworks Holdings, Inc. (DNA) worth $615,795, representing 0.00% of the portfolio. First purchased in 2022-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in DNA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2024, adding 159,173 shares. Largest reduction occurred in Q1 2025, reducing 114,654 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Ginkgo Bioworks Holdings (DNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ginkgo Bioworks Holdings (DNA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +100,456 | New Buy | 100,456 | $6.13 |
| Q1 2025 | -114,654 | Sold Out | 0 | $0.00 |
| Q4 2024 | +45,200 | Add 65.08% | 114,654 | $9.82 |
| Q3 2024 | -89,719 | Reduce 56.37% | 69,454 | $8.15 |
| Q2 2024 | +159,173 | New Buy | 159,173 | $13.37 |
| Q3 2022 | -78,535 | Sold Out | 0 | $0.00 |
| Q2 2022 | +44,553 | Add 131.11% | 78,535 | $95.21 |
| Q1 2022 | +33,982 | New Buy | 33,982 | $161.20 |
Renaissance Technologies (RenTech)'s Ginkgo Bioworks Holdings Investment FAQs
Renaissance Technologies (RenTech) first purchased Ginkgo Bioworks Holdings, Inc. (DNA) in Q1 2022, acquiring 33,982 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Ginkgo Bioworks Holdings, Inc. (DNA) for 8 quarters since Q1 2022.
Renaissance Technologies (RenTech)'s largest addition to Ginkgo Bioworks Holdings, Inc. (DNA) was in Q2 2024, adding 159,173 shares worth $2.13 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 100,456 shares of Ginkgo Bioworks Holdings, Inc. (DNA), valued at approximately $615,795.
As of the Q1 2026 filing, Ginkgo Bioworks Holdings, Inc. (DNA) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Ginkgo Bioworks Holdings, Inc. (DNA) was 159,173 shares, as reported at the end of Q2 2024.